• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

a year ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Iran-Israel Conflict Accelerates Shift to Petroyuan

chest

The ongoing Iran-Israel conflict is impacting the US dollar's dominance, with Iran allowing oil payments in yuan, potentially leading to the rise of the petroyuan.

user avatarBayarjavkhlan Ganbaatar

Rycroft Review Proposes Capping Overseas Donations to Political Parties

chest

The Rycroft review recommends capping overseas donations from UK citizens living abroad at £100,000 per year to regulate foreign financial influence in UK politics.

user avatarElias Mukuru

Reform UK Protests Against Cryptocurrency Donation Ban

chest

Reform UK members protested against the cryptocurrency donation ban by walking out of Parliament, criticizing the government's stance on crypto.

user avatarMohamed Farouk

UK Government Bans Cryptocurrency Donations to Political Parties

chest

UK Prime Minister Keir Starmer announces a ban on cryptocurrency donations to political parties following a review into foreign financial influence.

user avatarDiego Alvarez

Trump Appoints Tech Leaders to Presidents Council of Advisors on Science and Technology

chest

President Trump has appointed notable tech leaders to the Presidents Council of Advisors on Science and Technology.

user avatarKenji Takahashi

Bank of America Reinstates Buy Rating for Oracle Stock

chest

On March 24, Bank of America analyst Tal Liani reinstated a Buy rating for Oracle stock with a price target of $200, indicating a potential upside of 30%.

user avatarMaria Fernandez

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.